Elanco Animal Health Incorporated (ELAN) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Elanco Animal Health Incorporated (ELAN) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

ELAN Cash Flow Statement

Elanco Animal Health Incorporated (ELAN) cash flow statement — 10-year operating, investing & financing cash flows

Annual Quarterly

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	277M	13M	108M	219M	237M	-4M	177M	162M	200M	2M	157M	198M	61M	-145M	13M	189M	312M	-62M	223M	89M
Operating CF Margin %	20.25%	0.95%	9.44%	19.26%	19.1%	-0.34%	17.35%	15.73%	16.89%	0.17%	15.17%	18.54%	5.77%	-11.54%	1.32%	18.42%	26.55%	-5.06%	20.04%	7.87%
Operating CF Growth %	16.88%	425%	-38.98%	35.19%	18.5%	-300%	12.74%	-18.18%	227.87%	101.38%	1107.69%	4.76%	-80.45%	-133.87%	-94.17%	112.36%	109.4%	-381.82%	340.04%	179.68%
Net Income	54M	57M	-232M	-34M	11M	67M	-8M	364M	-50M	32M	-141M	-1.1B	-97M	103M	-55M	-49M	-22M	48M	-97M	-104M
Depreciation & Amortization	171M	172M	174M	176M	169M	161M	164M	170M	162M	166M	171M	173M	177M	173M	168M	167M	171M	176M	174M	170M
Stock-Based Compensation	20M	21M	16M	17M	20M	15M	15M	15M	14M	11M	15M	10M	9M	12M	15M	13M	17M	14M	18M	17M
Deferred Taxes	0	0	-134M	0	0	0	0	0	0	0	-53M	1.05B	-3M	2M	-21M	4M	-29M	-11M	-35M	-5M
Other Non-Cash Items	8M	26M	59M	297M	-15M	-10M	32M	-542M	52M	-30M	19M	37M	9M	4M	-16M	69M	213M	42M	7M	64M
Working Capital Changes	24M	-263M	225M	-237M	52M	-237M	-26M	155M	22M	-177M	146M	27M	-34M	-439M	-78M	-15M	-38M	-331M	156M	-53M
Change in Receivables	0	0	0	0	0	0	12M	0	0	0	-40M	0	0	0	14M	0	0	0	-25M	0
Change in Inventory	0	0	0	0	0	0	44M	0	0	0	-160M	0	0	0	-269M	0	0	0	27M	0
Change in Payables	0	0	0	0	0	0	0	0	0	0	200M	0	0	0	-98M	0	0	0	-120M	0
Cash from Investing	-110M	-60M	-64M	-101M	-56M	-58M	-90M	1.24B	-33M	37M	-35M	-36M	-43M	-55M	-76M	-37M	-37M	-29M	-74M	-441M
Capital Expenditures	-33M	-51M	-62M	-92M	-57M	-65M	-47M	-42M	-34M	-24M	-41M	-33M	-42M	-38M	-79M	-46M	-33M	-26M	-66M	-25M
CapEx % of Revenue	2.41%	3.72%	5.42%	8.09%	4.59%	5.45%	4.61%	4.08%	2.87%	1.99%	3.96%	3.09%	3.97%	3.02%	8%	4.48%	2.81%	2.12%	5.93%	2.21%
Acquisitions	-76M	0	-7M	7M	-7M	9M	-36M	5M	0	-5M	0	-3M	0	-16M	2M	11M	0	0	0	-415M
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	-1M	-9M	5M	-16M	8M	-2M	-7M	1.28B	1M	66M	6M	0	-1M	-1M	1M	-2M	-4M	-3M	-8M	-1M
Cash from Financing	-74M	-65M	-18M	-153M	-156M	52M	-32M	-1.34B	-93M	-27M	-139M	-157M	39M	174M	-84M	-169M	-96M	-200M	44M	231M
Debt Issued (Net)	-73M	-16M	562M	102M	-446M	72M	-38M	-1.33B	-92M	-13M	-139M	-156M	37M	181M	-70M	-154M	-89M	-189M	46M	232M
Equity Issued (Net)	34M	-34M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	34M	-34M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	-35M	-15M	-580M	-255M	290M	-20M	6M	-8M	-1M	-14M	0	-1M	2M	-7M	-14M	-15M	-7M	-11M	-2M	-1M
Net Change in Cash	102M	-117M	40M	-34M	52M	19M	-22M	74M	71M	-7M	-17M	2M	49M	-27M	-115M	-47M	165M	-296M	185M	-127M
Free Cash Flow	244M	-38M	46M	127M	180M	-69M	124M	120M	166M	-22M	116M	165M	19M	-183M	-66M	143M	279M	-88M	132M	64M
FCF Margin %	17.84%	-2.77%	4.02%	11.17%	14.5%	-5.78%	12.16%	11.65%	14.02%	-1.83%	11.21%	15.45%	1.8%	-14.56%	-6.68%	13.94%	23.74%	-7.18%	11.86%	5.66%
FCF Growth %	35.56%	44.93%	-62.9%	5.83%	8.43%	-213.64%	6.9%	-27.27%	773.68%	87.98%	275.76%	15.38%	-93.19%	-107.95%	-150%	123.44%	125%	-158.82%	155.05%	129.62%
FCF per Share	0.48	-0.08	0.09	0.26	0.36	-0.14	0.25	0.24	0.34	-0.04	0.24	0.33	0.04	-0.37	-0.14	0.29	0.57	-0.18	0.27	0.13
FCF Conversion (FCF/Net Income)	5.13x	0.23x	-0.39x	-6.44x	21.55x	-0.06x	-22.13x	0.45x	-4.00x	0.06x	-1.11x	-0.18x	-0.63x	-1.41x	-0.24x	-2.91x	-31.20x	-1.22x	-2.14x	-0.86x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0